Keywords: glaxo, wellcome/vertex, agenerase, wins, accelerated, fda, approval
Glaxo Wellcome/Vertex' Agenerase wins accelerated FDA approval
Article | 21 April 1999
The US Food and Drug Administration has granted accelerated approval forGlaxo Wellcome's Agenerase (amprenavir), a protease inhibitor that is commonly ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
